Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2024-03-20 | Advantech Capital L.P. | SINOVAC BIOTECH LTD | 5,851,423 | 8.2% | EDGAR |
SC 13D/A | 2023-12-04 | SAIF Partners IV L.P. | SINOVAC BIOTECH LTD | 10,780,820 | 15.0% | EDGAR |
SC 13D/A | 2023-09-15 | SAIF Partners IV L.P. | SINOVAC BIOTECH LTD | 10,780,820 | 15.0% | EDGAR |
SC 13D/A | 2023-05-25 | SAIF Partners IV L.P. | SINOVAC BIOTECH LTD | 10,780,820 | 15.0% | EDGAR |
SC 13D/A | 2023-03-15 | SAIF Partners IV L.P. | SINOVAC BIOTECH LTD | 10,780,820 | 15.0% | EDGAR |
SC 13D/A | 2022-12-12 | SAIF Partners IV L.P. | SINOVAC BIOTECH LTD | 10,780,820 | 15.0% | EDGAR |
SC 13D | 2020-12-22 | CDH Fund VI, L.P. | SINOVAC BIOTECH LTD | 6,000,000 | 8.4% | EDGAR |
SC 13D/A | 2020-12-21 | 1Globe Capital LLC | SINOVAC BIOTECH LTD | 18,515,315 | 32.3% | EDGAR |
SC 13D/A | 2019-03-19 | 1Globe Capital LLC | SINOVAC BIOTECH LTD | 9,353,092 | 16.3% | EDGAR |
SC 13D/A | 2018-08-27 | Vivo Capital, LLC | SINOVAC BIOTECH LTD | 0 | 0.0% | EDGAR |
SC 13D/A | 2018-07-20 | Vivo Capital, LLC | SINOVAC BIOTECH LTD | 4,539,456 | 6.6% | EDGAR |
SC 13D | 2018-07-11 | Vivo Capital, LLC | SINOVAC BIOTECH LTD | 5,900,000 | 8.5% | EDGAR |
SC 13G | 2018-07-10 | Advantech Capital L.P. | SINOVAC BIOTECH LTD | 5,900,000 | 8.5% | EDGAR |
SC 13D/A | 2018-03-26 | 1Globe Capital LLC | SINOVAC BIOTECH LTD | 9,353,092 | 16.4% | EDGAR |
SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | SINOVAC BIOTECH LTD | 69,098 | 0.1% | EDGAR |
SC 13D | 2017-07-07 | 1Globe Capital LLC | SINOVAC BIOTECH LTD | 9,353,092 | 16.4% | EDGAR |
SC 13D/A | 2017-06-27 | WEIDONG YIN | SINOVAC BIOTECH LTD | 6,124,500 | 10.7% | EDGAR |
SC 13D/A | 2017-06-27 | SAIF Partners IV L.P. | SINOVAC BIOTECH LTD | 10,780,820 | 18.9% | EDGAR |
SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | SINOVAC BIOTECH LTD | 5,521,262 | 9.7% | EDGAR |
SC 13G | 2016-04-11 | Li Chiang Family | SINOVAC BIOTECH LTD | 3,459,763 | 6.1% | EDGAR |